title: [Vaniprevir with pegylated interferon and ribavirin in treatment for chronic hepatitis C].
authors: Tetsuo
authors: T
authors: Takehara
mesh_terms: D002986:Clinical Trials as Topic; D003521:Cyclopropanes; D004338:Drug Combinations; D024882:Drug Resistance, Viral; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use*; D054833:Isoindoles; D047029:Lactams, Macrocyclic; D007930:Leucine / Q000031:analogs & derivatives; D011392:Proline / Q000031:analogs & derivatives; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*; D013449:Sulfonamides
chemical_list: D003521:Cyclopropanes; D004338:Drug Combinations; D007211:Indoles; D054833:Isoindoles; D047029:Lactams, Macrocyclic; D013449:Sulfonamides; D012254:Ribavirin; D007372:Interferons; D011392:Proline; C540393:vaniprevir; D007930:Leucine